COVID-19期间的临床试验:在本次大流行期间向临床试验参与者通报情况

Wong Lx, B. Chee, Park Jm
{"title":"COVID-19期间的临床试验:在本次大流行期间向临床试验参与者通报情况","authors":"Wong Lx, B. Chee, Park Jm","doi":"10.15761/crt.1000312","DOIUrl":null,"url":null,"abstract":"Currently, per the World Health Organization (WHO), the novel coronavirus disease 2019 (COVID-19) surpassed five million confirmed cases and the numbers continue to alarmingly climb world-wide [1]. COVID-19 is caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inducing potentially lifethreatening circumstances in all age ranges, primarily in that of 3065 [2]. Especially in light of early studies showing COVID-19 patients with co-morbidities likely to have more severe symptoms and increase risk of death than that of those who did not have co-morbidities [3,4], global municipalities, states and countries have enacted a various forms of quarantine strategies to mitigate the adverse effects of COVID-19 on people and our global society [5].","PeriodicalId":90808,"journal":{"name":"Clinical research and trials","volume":"1 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2020-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":"{\"title\":\"Clinical trials during COVID-19: Keeping clinical trial participants informed during this pandemic\",\"authors\":\"Wong Lx, B. Chee, Park Jm\",\"doi\":\"10.15761/crt.1000312\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Currently, per the World Health Organization (WHO), the novel coronavirus disease 2019 (COVID-19) surpassed five million confirmed cases and the numbers continue to alarmingly climb world-wide [1]. COVID-19 is caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inducing potentially lifethreatening circumstances in all age ranges, primarily in that of 3065 [2]. Especially in light of early studies showing COVID-19 patients with co-morbidities likely to have more severe symptoms and increase risk of death than that of those who did not have co-morbidities [3,4], global municipalities, states and countries have enacted a various forms of quarantine strategies to mitigate the adverse effects of COVID-19 on people and our global society [5].\",\"PeriodicalId\":90808,\"journal\":{\"name\":\"Clinical research and trials\",\"volume\":\"1 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2020-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"1\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical research and trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/crt.1000312\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical research and trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/crt.1000312","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1

摘要

目前,根据世界卫生组织(世卫组织)的数据,2019年新型冠状病毒病(COVID-19)确诊病例超过500万例,全球确诊病例数继续惊人地攀升。COVID-19是由一种严重急性呼吸系统综合征冠状病毒2 (SARS-CoV-2)引起的,可在所有年龄段(主要是3065岁)中诱发潜在的危及生命的情况。特别是考虑到早期研究显示,与无合并症的患者相比,患有COVID-19合并症的患者可能有更严重的症状,死亡风险更高[3,4],全球各城市、州和国家已制定了各种形式的隔离策略,以减轻COVID-19对人类和全球社会的不利影响。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Clinical trials during COVID-19: Keeping clinical trial participants informed during this pandemic
Currently, per the World Health Organization (WHO), the novel coronavirus disease 2019 (COVID-19) surpassed five million confirmed cases and the numbers continue to alarmingly climb world-wide [1]. COVID-19 is caused by a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) inducing potentially lifethreatening circumstances in all age ranges, primarily in that of 3065 [2]. Especially in light of early studies showing COVID-19 patients with co-morbidities likely to have more severe symptoms and increase risk of death than that of those who did not have co-morbidities [3,4], global municipalities, states and countries have enacted a various forms of quarantine strategies to mitigate the adverse effects of COVID-19 on people and our global society [5].
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信